Eye health starts at the surface
MGD is a chronic, progressive and obstructive condition. Approximately 1 in 5 patients with MGD are asymptomatic.4
EVALUATE. TREAT. SUCCEED. MGD (Meibomian gland dysfunction) is a chronic, progressive and unobstructive condition. TearScience™ enables enhanced ocular surface protection.1
MGD is a chronic, progressive and obstructive condition. Approximately 1 in 5 patients with MGD are asymptomatic.4
PP2023OTH5911
Overview
Useful Links
Legal
Additional Information
© Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc. 2024 All rights reserved. This site is published by Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc., which are solely responsible for its content.
Third party trademarks used herein are trademarks of their respective owners.
Vision Made Possible™